Trials / Completed
CompletedNCT05800691
Predicting Factors for Mortality in Congenital Heart Disease Patients After Shunt Procedure in Developing Country.
Predicting Factors for Mortality in Patients After the Modified Blalock-Taussig Shunt Procedure in Developing Country: a Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 197 (actual)
- Sponsor
- Universitas Sumatera Utara · Academic / Other
- Sex
- All
- Age
- 1 Day – 18 Years
- Healthy volunteers
- —
Summary
Blalock Taussig (BT) is a palliative procedure that preserves blood circulation to the lungs and alleviates cyanosis in patients with congenital heart diseases and reduced pulmonary blood flow. BT shunt remains a routinely performed procedure in developing countries before definitive surgery. However, evidence on predictors factors of mortality after this procedure is still scarce in Indonesia.
Conditions
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2021-01-31
- Completion
- 2021-01-31
- First posted
- 2023-04-05
- Last updated
- 2023-08-08
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT05800691. Inclusion in this directory is not an endorsement.